Provein Safe 24G IV Cannula

The Provein Safe 24G IV Cannula is a specialised small-gauge peripheral venous access device designed for neonatal patients, infants, and adults with extremely fragile or compromised veins. This yellow-coded cannula provides the gentlest possible insertion whilst maintaining adequate flow rates for medication administration, hydration, and specialised infusion therapy. Manufactured by LARS Medicare, a family-run medical device company with over 20 years of ISO 13485-certified manufacturing excellence, the Provein Safe 24G combines clinical performance with integrated safety features to protect healthcare professionals from needlestick injuries.​​ Key Clinical Applications Neonatal intensive care unit (NICU) venous access Infant and young paediatric patient infusions Extremely fragile veins in oncology or immunocompromised patients Very elderly patients with severely compromised peripheral vessels Scalp vein cannulation in neonates and infants Long-term infusion therapy requiring minimal vein trauma Technical Specifications Specification Details Gauge Size 24G (0.7mm outer diameter) Colour Coding Yellow (international standard) Catheter Material PTFE (Polytetrafluoroethylene) – biocompatible, ultra-smooth Needle Material Medical-grade stainless steel, precision-ground bevel Catheter Length 19mm (suitable for neonatal/infant vessels) Flow Rate ~20-24 ml/min (low-flow specialised access)​ Safety Mechanism Integrated one-handed needle safety device Design Features Flexible wings, injection port for secondary access Sterility ETO sterilised, individually sealed packaging​ Latex Status Latex-free (hypoallergenic) Design Features & Clinical Benefits PTFE Catheter Technology The Provein Safe 24G utilises PTFE catheter material, the gold standard for biocompatibility and ultra-smooth insertion. PTFE’s low-friction coefficient is essential in neonatal and infant populations where vessel walls are delicate and any trauma can compromise future vascular access sites. The material’s exceptional flexibility accommodates tiny vessel movement during patient activity whilst maintaining catheter patency in challenging anatomical locations.​ Integrated Safety Mechanism One-handed needle safety activation shields the sharp needle immediately after catheter insertion, reducing needlestick injury risk by over 80% compared to conventional cannulas. For neonatal and paediatric nursing specialists who frequently work with distressed or moving patients in confined spaces, this feature provides essential protection whilst maintaining full attention on precise insertion technique and patient safety.​ Clear Flashback Chamber Transparent flashback chamber provides immediate visual confirmation of successful venipuncture, critically important when accessing tiny neonatal vessels where flashback volume may be minimal. In NICU and specialised paediatric settings where each vascular access attempt must succeed due to limited alternative sites, reliable flashback visibility supports clinical precision and reduces patient distress from repeated attempts.​ Flexible Wings & Injection Port Bilateral stabilisation wings provide ergonomic handling during insertion and secure fixation with specialised neonatal tape or transparent dressings, essential for maintaining catheter position in active infants. The integrated injection port allows secondary medication administration (antibiotics, vaccines, emergency medications) without disturbing the primary infusion or risking catheter displacement in these vulnerable patients.​ When to Choose 24G vs. Other Gauges 24G is optimal when:​ Neonatal patients requiring peripheral venous access Infants and young children with very small peripheral veins Oncology patients with severely compromised vascular integrity Very elderly patients where 22G insertion repeatedly fails Scalp vein cannulation in neonates Situations requiring minimal vessel trauma and maximum catheter dwell time Choose 22G instead when:​ Older paediatric patients (school-age children) with adequate vein calibre Elderly patients with fragile but not severely compromised veins Higher flow rates (36 ml/min) clinically required Standard paediatric or geriatric infusion scenarios Choose 26G instead when:​ Extremely premature neonates with micro-vessels Failed 24G insertion attempts due to vessel size Situations where 24G causes visible vessel distension Specialised Use in Neonatal & Critical Vein Preservation The 24G cannula represents a critical tool in neonatal intensive care and specialised paediatric medicine. For neonates weighing 2-4kg, the 24G provides adequate flow for total parenteral nutrition (TPN), antibiotics, and essential medications whilst preserving delicate vessels for future access needs. In oncology and haematology settings, where patients undergo repeated venous access over months or years of treatment, the 24G’s minimal vessel trauma profile significantly extends the lifespan of peripheral access sites. The reduced gauge also decreases mechanical phlebitis risk, a major concern when infusing irritant medications through small vessels. Neonatal nurses and paediatric specialists rely on 24G cannulas as their primary tool for scalp vein access, hand veins, and distal forearm vessels in the smallest patients.​ Manufactured by LARS Medicare: Family-Trusted Quality Since 2005 LARS Medicare Pvt. Ltd. is a family-run medical device manufacturer with over 20 years of proven excellence in IV cannula production. Founded by Sanjay Goel in 2005 and now managed across two generations of the Goel family, LARS Medicare embodies consistent quality, long-term partnership, and unwavering commitment to healthcare professionals worldwide.​ Quality Credentials:​​ ISO 13485:2003 Certified – Medical device quality management systems CE Marked – Recognised for Great Britain market​ MHRA Registered – Approved for UK distribution In-House Testing Laboratory – Three-level quality validation at every production stage​ Computer-Controlled EO Sterilisation – Consistent, validated sterilisation processes​ Exported to over 70 countries across Asia Pacific, Latin America, Europe, and beyond, LARS Medicare products have earned international recognition for reliability and clinical performance.​ Regulatory Compliance & Safety CE Marked: EU Medical Device Regulation compliant; recognised in Great Britain​ MHRA Registered: Approved for distribution in England, Wales, and Scotland UK Responsible Person: Reflex Medical Limited, Salford, England Single-Use Device: Sterile, non-pyrogenic, intended for one-time use only Latex-Free: Suitable for patients with latex allergies Biocompatibility Testing: Complies with ISO 10993 standards Ordering Information Packaging: 50 units per box, individually sterile packed Bulk Ordering: Available for NHS framework suppliers and hospital procurement teams Stock: Held in UK for rapid delivery across England, Wales, and Scotland